Streptococcal M proteins and their role as virulence determinants

Clinica Chimica Acta

Volumn 411, Issue 17-18, 2010, Pages 1172-1180

  Oehmcke, Sonja ^a   Shannon, Oonagh ^a   Mörgelin, Matthias ^a   Herwald, Heiko ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

Group A streptococci; M protein

Indexed keywords

FIBRONECTIN; GLYCOSAMINOGLYCAN; M PROTEIN; MEMBRANE COFACTOR PROTEIN; BACTERIAL PROTEIN;

BACTERIAL COLONIZATION; BACTERIAL VIRULENCE; CROSS REACTION; GROUP A STREPTOCOCCAL INFECTION; HEMOSTASIS; HOST CELL; INTERNALIZATION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW; RHEUMATIC FEVER; SEROTYPE; STREPTOCOCCUS GROUP A; STREPTOCOCCUS INFECTION; AUTOPHAGY; BACTERIUM ADHERENCE; CHEMISTRY; HUMAN; MOLECULAR MIMICRY; PATHOGENICITY; PHYSIOLOGY; PROTEIN CONFORMATION; STREPTOCOCCUS PYOGENES; TRANSMISSION ELECTRON MICROSCOPY; ULTRASTRUCTURE; VIRULENCE;

AUTOPHAGY; BACTERIAL ADHESION; BACTERIAL PROTEINS; HEMOSTASIS; HUMANS; MICROSCOPY, ELECTRON, TRANSMISSION; MOLECULAR MIMICRY; PROTEIN CONFORMATION; STREPTOCOCCUS PYOGENES; VIRULENCE;

STREPTOCOCCUS PYOGENES; STREPTOCOCCUS SP. 'GROUP A';

EID: 77954144724     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2010.04.032     Document Type: Review

References (136)

1. Steer A.C., Law I., Matatolu L., Beall B.W., Carapetis J.R. Global emm type distribution of group A streptococci: systematic review and implications for vaccine development. Lancet Infect Dis 2009, 9:611-616.
2. Lancefield R.C. A serological differentiation of human and other groups of hemolytic streptococci. J Exp Med 1933, 57:571-595.
3. Carapetis J.R., Steer A.C., Mulholland E.K., Weber M. The global burden of group A streptococcal diseases. Lancet Infect Dis 2005, 5:685-694.
4. Fischetti V.A. Streptococcal M protein: molecular design and biological behaviour. Clin Microbiol Rev 1989, 2:285-314.
5. Fischetti V.A. Streptococcal M protein. Sci Am 1991, 264:58-65.
6. McNamara C., Zinkernagel A.S., Macheboeuf P., Cunningham M.W., Nizet V., Ghosh P. Coiled-coil irregularities and instabilities in group A Streptococcus M1 are required for virulence. Science 2008, 319:1405-1408.
7. Fischetti V.A., Pancholi V., Schneewind O. Conservation of a hexapeptide sequence in the anchor region of surface proteins from gram-positive cocci. Mol Microbiol 1990, 4:1603-1605.
8. Hollingshead S.K., Fischetti V.A., Scott J.R. A highly conserved region present in transcripts encoding heterologous M proteins of group A streptococci. Infect Immun 1987, 55:3237-3239.
9. Ringdahl U., Svensson H.G., Kotarsky H., Gustafsson M., Weineisen M., Sjöbring U. A role for the fibrinogen-binding regions of streptococcal M proteins in phagocytosis resistance. Mol Microbiol 2000, 37:1318-1326.
10. de Malmanche S.A., Martin D.R. Protective immunity to the group A Streptococcus may be only strain specific. Med Microbiol Immunol 1994, 183:299-306.
11. Musser J.M., Kapur V., Szeto J., Pan X., Swanson D.S., Martin D.R. Genetic diversity and relationships among Streptococcus pyogenes strains expressing serotype M1 protein: recent intercontinental spread of a subclone causing episodes of invasive disease. Infect Immun 1995, 63:994-1003.
12. Penney T.J., Martin D.R., Williams L.C., de Malmanche S.A., Bergquist P.L. A single emm gene-specific oligonucleotide probe does not recognise all members of the Streptococcus pyogenes M type 1. FEMS Microbiol Lett 1995, 130:145-149.
13. Bessen D., Jones K.F., Fischetti V.A. Evidence for two distinct classes of streptococcal M protein and their relationship to rheumatic fever. J Exp Med 1989, 169:269-283.
14. Bessen D.E., Fischetti V.A. Differentiation between two biologically distinct classes of group A streptococci by limited substitutions of amino acids within the shared region of M protein-like molecules. J Exp Med 1990, 172:1757-1764.
15. Saravani G.A., Martin D.R. Characterisation of opacity factor from group-A streptococci. J Med Microbiol 1990, 33:55-60.
16. Saravani G.A., Martin D.R. Opacity factor from group A streptococci is an apoproteinase. FEMS Microbiol Lett 1990, 56:35-39.
17. Bessen D.E., Veasy L.G., Hill H.R., Augustine N.H., Fischetti V.A. Serologic evidence for a class I group A streptococcal infection among rheumatic fever patients. J Infect Dis 1995, 172:1608-1611.
18. Nordstrand A., Norgren M., Holm S.E. Pathogenic mechanism of acute post-streptococcal glomerulonephritis. Scand J Infect Dis 1999, 31:523-537.
19. Cunningham M.W. Pathogenesis of group A streptococcal infections. Clin Microbiol Rev 2000, 13:470-511.
20. Kaplan M.H., Meyeserian M. An immunological cross-reaction between group-A streptococcal cells and human heart tissue. Lancet 1962, 1:706-710.
21. Dale J.B., Beachey E.H. Protective antigenic determinant of streptococcal M protein shared with sarcolemmal membrane protein of human heart. J Exp Med 1982, 156:1165-1176.
22. Dale J.B., Beachey E.H. Protective antibody against a peptide fragment of type 5 streptococcal M protein cross-reacts with human heart tissue. Trans Assoc Am Physicians 1982, 95:286-291.
23. Guilherme L., Fae K.C., Oshiro S.E., Tanaka A.C., Pomerantzeff P.M., Kalil J. T cell response in rheumatic fever: crossreactivity between streptococcal M protein peptides and heart tissue proteins. Curr Protein Pept Sci 2007, 8:39-44.
24. Guilherme L., Kalil J., Cunningham M. Molecular mimicry in the autoimmune pathogenesis of rheumatic heart disease. Autoimmunity 2006, 39:31-39.
25. Dinkla K., Rohde M., Jansen W.T., Kaplan E.L., Chhatwal G.S., Talay S.R. Rheumatic fever-associated Streptococcus pyogenes isolates aggregate collagen. J Clin Invest 2003, 111:1905-1912.
26. Rodríguez-Iturbe B., Batsford S. Pathogenesis of poststreptococcal glomerulonephritis a century after Clemens von Pirquet. Kidney Int 2007, 71:1094-1104.
27. Beall B., Facklam R., Thompson T. Sequencing emm-specific PCR products for routine and accurate typing of group A streptococci. J Clin Microbiol 1996, 34:953-958.
28. Facklam R. What happened to the streptococci: overview of taxonomic and nomenclature changes. Clin Microbiol Rev 2002, 15:613-630.
29. O'Loughlin R.E., Roberson A., Cieslak P.R., et al. The epidemiology of invasive group A streptococcal infection and potential vaccine implications: United States, 2000-2004. Clin Infect Dis 2007, 45:853-862.
30. Luca-Harari B., Darenberg J., Neal S., et al. Clinical and microbiological characteristics of severe Streptococcus pyogenes disease in Europe. J Clin Microbiol 2009, 47:1155-1165.
31. Colman G., Tanna A., Efstratiou A., Gaworzewska E.T. The serotypes of Streptococcus pyogenes present in Britain during 1980-1990 and their association with disease. J Med Microbiol 1993, 39:165-178.
32. Mencarelli M., Corbisiero R., Padula M.G., Galgani I., Stolzuoli L., Cellesi C. Group A streptococcal infections: trend and strain emm typing in an area of central Italy, 1985-2002. Epidemiol Infect 2005, 133:1107-1111.
33. Strakova L., Motlova J., Urbaskova P., Krizova P. Surveillance of serious diseases caused by group A streptococci in the Czech Republic in 2003-the Strep-EURO project. Epidemiol Mikrobiol Imunol 2004, 53:106-111.
34. Raymond J., Schlegel L., Garnier F., Bouvet A. Molecular characterization of Streptococcus pyogenes isolates to investigate an outbreak of puerperal sepsis. Infect Control Hosp Epidemiol 2005, 26:455-461.
35. Talay S.R. Gram-positive adhesins. Contrib Microbiol 2005, 12:90-113.
36. Courtney H.S., Hasty D.L., Dale J.B. Molecular mechanisms of adhesion, colonization, and invasion of group A streptococci. Ann Med 2002, 34:77-87.
37. Ellen R.P., Gibbons R.J. M protein-associated adherence of Streptococcus pyogenes to epithelial surfaces: prerequisite for virulence. Infect Immun 1972, 5:826-830.
38. Ellen R.P., Gibbons R.J. Parameters affecting the adherence and tissue tropisms of Streptococcus pyogenes. Infect Immun 1974, 9:85-91.
39. Courtney H.S., von Hunolstein C., Dale J.B., Bronze M.S., Beachey E.H., Hasty D.L. Lipoteichoic acid and M protein: dual adhesins of group A streptococci. Microb Pathog 1992, 12:199-208.
40. Wang J.R., Stinson M.W. M protein mediates streptococcal adhesion to HEp-2 cells. Infect Immun 1994, 62:442-448.
41. Courtney H.S., Ofek I., Hasty D.L. M protein mediated adhesion of M type 24 Streptococcus pyogenes stimulates release of interleukin-6 by HEp-2 tissue culture cells. FEMS Microbiol Lett 1997, 151:65-70.
42. Courtney H.S., Ofek I., Simpson W.A., Hasty D.L., Beachey E.H. Binding of Streptococcus pyogenes to soluble and insoluble fibronectin. Infect Immun 1986, 53:454-459.
43. Sanford B.A., Davison V.E., Ramsay M.A. Fibrinogen-mediated adherence of group A Streptococcus to influenza A virus-infected cell cultures. Infect Immun 1982, 38:513-520.
44. Cue D., Lam H., Cleary P.P. Genetic dissection of the Streptococcus pyogenes M1 protein: regions involved in fibronectin binding and intracellular invasion. Microb Pathog 2001, 31:231-242.
45. Schmidt K.H., Mann K., Cooney J., Köhler W. Multiple binding of type 3 streptococcal M protein to human fibrinogen, albumin and fibronectin. FEMS Immunol Med Microbiol 1993, 7:135-143.
46. Joh D., Wann E.R., Kreikemeyer B., Speziale P., Höök M. Role of fibronectin-binding MSCRAMMs in bacterial adherence and entry into mammalian cells. Matrix Biol 1999, 18:211-223.
47. Kreikemeyer B., Oehmcke S., Nakata M., Hoffrogge R., Podbielski A. Streptococcus pyogenes fibronectin-binding protein F2: expression profile, binding characteristics, and impact on eukaryotic cell interactions. J Biol Chem 2004, 279:15850-15859.
48. Oehmcke S., Podbielski A., Kreikemeyer B. Function of the fibronectin-binding serum opacity factor of Streptococcus pyogenes in adherence to epithelial cells. Infect Immun 2004, 72:4302-4308.
49. Okada N., Liszewski M.K., Atkinson J.P., Caparon M. Membrane cofactor protein (CD46) is a keratinocyte receptor for the M protein of the group A streptococcus. Proc Natl Acad Sci U S A 1995, 92:2489-2493.
50. Giannakis E., Jokiranta T.S., Ormsby R.J., et al. Identification of the streptococcal M protein binding site on membrane cofactor protein (CD46). J Immunol 2002, 168:4585-4592.
51. Berkower C., Ravins M., Moses A.E., Hanski E. Expression of different group A streptococcal M proteins in an isogenic background demonstrates diversity in adherence to and invasion of eukaryotic cells. Mol Microbiol 1999, 31:1463-1475.
52. Feito M.J., Sánchez A., Oliver M.A., et al. Membrane cofactor protein (MCP, CD46) binding to clinical isolates of Streptococcus pyogenes: binding to M type 18 strains is independent of Emm or Enn proteins. Mol Immunol 2007, 44:3571-3579.
53. Frick I.M., Schmidtchen A., Sjöbring U. Interactions between M proteins of Streptococcus pyogenes and glycosaminoglycans promote bacterial adhesion to host cells. Eur J Biochem 2003, 270:2303-2311.
54. Frick I.-M., Mörgelin M., Björck L. Virulent aggregates of Streptococcus pyogenes are generated by homophilic protein-protein interactions. Mol Microbiol 2000, 37:1232-1247.
55. Nobbs A.H., Lamont R.J., Jenkinson H.F. Streptococcus adherence and colonization. Microbiol Mol Biol Rev 2009, 73:407-450.
56. Greco R., De Martino L., Donnarumma G., Conte M.P., Seganti L., Valenti P. Invasion of cultured human cells by Streptococcus pyogenes. Res Microbiol 1995, 146:551-560.
57. LaPenta D., Rubens C., Chi E., Cleary P.P. Group A streptococci efficiently invade human respiratory epithelial cells. Proc Natl Acad Sci U S A 1994, 91:12115-12119.
58. Molinari G., Chhatwal G.S. Invasion and survival of Streptococcus pyogenes in eukaryotic cells correlates with the source of the clinical isolates. J Infect Dis 1998, 177:1600-1607.
59. Cue D., Dombek P.E., Lam H., Cleary P.P. Streptococcus pyogenes serotype M1 encodes multiple pathways for entry into human epithelial cells. Infect Immun 1998, 66:4593-4601.
60. Rohde M., Müller E., Chhatwal G.S., Talay S.R. Host cell caveolae act as an entry-port for group A streptococci. Cell Microbiol 2003, 5:323-342.
61. Dombek P.E., Cue D., Sedgewick J., et al. High-frequency intracellular invasion of epithelial cells by serotype M1 group A streptococci: M1 protein-mediated invasion and cytoskeletal rearrangements. Mol Microbiol 1999, 31:859-870.
62. Purushothaman S.S., Wang B., Cleary P.P. M1 protein triggers a phosphoinositide cascade for group A Streptococcus invasion of epithelial cells. Infect Immun 2003, 71:5823-5830.
63. Rezcallah M.S., Hodges K., Gill D.B., Atkinson J.P., Wang B., Cleary P.P. Engagement of CD46 and alpha5beta1 integrin by group A streptococci is required for efficient invasion of epithelial cells. Cell Microbiol 2005, 7:645-653.
64. Fluckiger U., Jones K.F., Fischetti V.A. Immunoglobulins to group A streptococcal surface molecules decrease adherence to and invasion of human pharyngeal cells. Infect Immun 1998, 66:974-979.
65. Jadoun J., Burstein E., Hanski E., Sela S. Proteins M6 and F1 are required for efficient invasion of group A streptococci into cultured epithelial cells. Adv Exp Med Biol 1997, 418:511-515.
66. Nitsche-Schmitz D.P., Rohde M., Chhatwal G.S. Invasion mechanisms of Gram-positive pathogenic cocci. Thromb Haemost 2007, 98:488-496.
67. Osterlund A., Popa R., Nikkilä T., Scheynius A., Engstrand L. Intracellular reservoir of Streptococcus pyogenes in vivo: a possible explanation for recurrent pharyngotonsillitis. Laryngoscope 1997, 107:640-647.
68. Podbielski A., Beckert S., Schattke R., et al. Epidemiology and virulence gene expression of intracellular group A streptococci in tonsils of recurrently infected adults. Int J Med Microbiol 2003, 293:179-190.
69. Moses A.E., Wessels M.R., Zalcman K., et al. Relative contributions of hyaluronic acid capsule and M protein to virulence in a mucoid strain of the group A Streptococcus. Infect Immun 1997, 65:64-71.
70. Rambach G., Würzner R., Speth C. Complement: an efficient sword of innate immunity. Contrib Microbiol 2008, 15:78-100.
71. Horstmann R.D., Sievertsen H.J., Knobloch J., Fischetti V.A. Antiphagocytic activity of streptococcal M protein: selective binding of complement control protein factor H. Proc Natl Acad Sci USA 1988, 85:1657-1661.
72. Kotarsky H., Hellwage J., Johnsson E., et al. Identification of a domain in human factor H and factor H-like protein-1 required for the interaction with streptococcal M proteins. J Immunol 1998, 160:3349-3354.
73. Perez Casal J., Price J.A., Maguin E., Scott J.R. An M protein with a single C repeat prevents phagocytosis of Streptococcus pyogenes: use of a temperature-sensitive shuttle vector to deliver homologous sequences to the chromosome of S. pyogenes. Mol Microbiol 1993, 8:809-819.
74. Kotarsky H., Gustafsson M., Svensson H.G., Zipfel P.F., Truedsson L., Sjöbring U. Group A streptococcal phagocytosis resistance is independent of complement factor H and factor H-like protein 1 binding. Mol Microbiol 2001, 41:817-826.
75. Johnsson E., Berggård K., Kotarsky H., et al. Role of the hypervariable region in streptococcal M proteins: binding of a human complement inhibitor. J Immunol 1998, 161:4894-4901.
76. Perez-Caballero D., Albertí S., Vivanco F., Sanchez-Corral P. Rodriguez de Córdoba S. Assessment of the interaction of human complement regulatory proteins with group A Streptococcus. Identification of a high-affinity group A Streptococcus binding site in FHL-1. Eur J Immunol 2000, 30:1243-1253.
77. Morfeldt E., Berggård K., Persson J., et al. Isolated hypervariable regions derived from streptococcal M proteins specifically bind human C4b-binding protein: implications for antigenic variation. J Immunol 2001, 167:3870-3877.
78. Berggård K., Johnsson E., Morfeldt E., Persson J., Stålhammar-Carlemalm M., Lindahl G. Binding of human C4BP to the hypervariable region of M protein: a molecular mechanism of phagocytosis resistance in Streptococcus pyogenes. Mol Microbiol 2001, 42:539-551.
79. Carlsson F., Berggård K., Stålhammar-Carlemalm M., Lindahl G. Evasion of phagocytosis through cooperation between two ligand-binding regions in Streptococcus pyogenes M protein. J Exp Med 2003, 198:1057-1068.
80. Whitnack E., Beachey E.H. Antiopsonic activity of fibrinogen bound to M protein on the surface of group A streptococci. J Clin Invest 1982, 69:1042-1045.
81. Whitnack E., Beachey E.H. Inhibition of complement-mediated opsonization and phagocytosis of Streptococcus pyogenes by D fragments of fibrinogen and fibrin bound to cell surface M protein. J Exp Med 1985, 162:1983-1997.
82. Whitnack E., Beachey E.H. Biochemical and biological properties of the binding of human fibrinogen to M protein in group A streptococci. J Bacteriol 1985, 164:350-358.
83. Horstmann R.D., Sievertsen H.J., Leippe M., Fischetti V.A. Role of fibrinogen in complement inhibition by streptococcal M protein. Infect Immun 1992, 60:5036-5041.
84. Carlsson F., Sandin C., Lindahl G. Human fibrinogen bound to Streptococcus pyogenes M protein inhibits complement deposition via the classical pathway. Mol Microbiol 2005, 56:28-39.
85. Berge A., Kihlberg B.M., Sjöholm A.G., Björck L. Streptococcal protein H forms soluble complement-activating complexes with IgG, but inhibits complement activation by IgG-coated targets. J Biol Chem 1997, 272:20774-20781.
86. Kronvall G. A surface component in group A, C, and G streptococci with non-immune reactivity for immunoglobulin G. J Immunol 1973, 111:1401-1406.
87. Forsgren A., Sjöquist J. "Protein A" from S. aureus. I. Pseudo-immune reaction with human gamma-globulin. J Immunol 1966, 97:822-827.
88. Reis K.J., Ayoub E.M., Boyle M.D. Streptococcal Fc receptors. I. Isolation and partial characterization of the receptor from a group C streptococcus. J Immunol 1984, 132:3091-3097.
89. Björck L., Kronvall G. Purification and some properties of streptococcal protein G, a novel IgG-binding reagent. J Immunol 1984, 133:969-974.
90. Björck L., Protein L. A novel bacterial cell wall protein with affinity for Ig L chains. J Immunol 1988, 140:1194-1197.
91. Frick I.M., Wikström M., Forsén S., et al. Convergent evolution among immunoglobulin G-binding bacterial proteins. Proc Natl Acad Sci USA 1992, 89:8532-8536.
92. Foley M.J., Smith M.R., Wood W.B. Studies on the pathogenicity of group A Streptococci. I. Its relation to surface phagocytosis. J Exp Med 1959, 110:603-816.
93. Foley M.J., Wood W.B. Studies on the pathogenicity of group A streptococci. II. The antiphagocytic effects of the M protein and the capsular gel. J Exp Med 1959, 110:617-628.
94. Manjula B.N. Molecular aspects of the phagocytosis resistance of group A streptococci. Eur J Epidemiol 1988, 4:289-300.
95. Weineisen M., Sjöbring U., Fällman M., Andersson T. Streptococcal M5 protein prevents neutrophil phagocytosis by interfering with CD11b/CD18 receptor-mediated association and signaling. J Immunol 2004, 172:3798-3807.
96. Staali L., Mörgelin M., Björck L., Tapper H. Streptococcus pyogenes expressing M and M-like surface proteins are phagocytosed but survive inside human neutrophils. Cell Microbiol 2003, 5:253-265.
97. Kantor F.S. Fibrinogen precipitation by streptococcal M protein. I. Identity of the reactants, and stoichiometry of the reaction. J Exp Med 1965, 121:849-859.
98. Kantor F.S. Fate of streptococcal M protein after exposure to plasmin and human leukocytes. Yale J Biol Med 1964, 36:259-267.
99. Walker M.J., McArthur J.D., McKay F., Ranson M. Is plasminogen deployed as a Streptococcus pyogenes virulence factor?. Trends Microbiol 2005, 13:308-313.
100. Herwald H., Mörgelin M., Dahlbäck B., Björck L. Interactions between surface proteins of Streptococcus pyogenes and coagulation factors modulate clotting of human plasma. J Thromb Haemost 2003, 1:284-291.
101. DeLa Cadena R.A., Laskin K.J., Pixley R.A., et al. Role of kallikrein-kinin system in pathogenesis of bacterial cell wall-induced inflammation. Am J Physiol 1991, 260:G213-G219.
102. Ben Nasr A.B., Herwald H., Müller-Esterl W., Björck L. Human kininogens interact with M protein, a bacterial surface protein and virulence determinant. Biochem J 1995, 305(Pt 1):173-180.
103. Ben Nasr A., Herwald H., Sjöbring U., Renné T., Müller-Esterl W., Björck L. Absorption of kininogen from human plasma by Streptococcus pyogenes is followed by the release of bradykinin. Biochem J 1997, 326(Pt 3):657-660.
104. Leeb-Lundberg L.M., Marceau F., Müller-Esterl W., Pettibone D.J., Zuraw B.L. International union of pharmacology. XLV. Classification of the kinin receptor family: from molecular mechanisms to pathophysiological consequences. Pharmacol Rev 2005, 57:27-77.
105. Cayla C., Todiras M., Iliescu R., et al. Mice deficient for both kinin receptors are normotensive and protected from endotoxin-induced hypotension. FASEB J 2007, 21:1689-1698.
106. Fein A.M., Bernard G.R., Criner G.J., et al. Treatment of severe systemic inflammatory response syndrome and sepsis with a novel bradykinin antagonist, deltibant (CP-0127). Results of a randomized, double-blind, placebo-controlled trial. CP-0127 SIRS and Sepsis Study Group. JAMA 1997, 277:482-487.
107. Sriskandan S., Kemball-Cook G., Moyes D., Canvin J., Tuddenham E., Cohen J. Contact activation in shock caused by invasive group A Streptococcus pyogenes. Crit Care Med 2000, 28:3684-3691.
108. Oehmcke S., Shannon O., von Köckritz-Blickwede M., et al. Treatment of invasive streptococcal infection with a peptide derived from human high-molecular weight kininogen. Blood 2009, 114:444-451.
109. Linder A., Johansson L., Thulin P., et al. Erysipelas caused by Group A Streptococcus activates the contact system and induces the release of heparin-binding protein. J Invest Dermatol 2010, 130:1365-1372.
110. Bryant A.E., Hayes-Schroer S.M., Stevens D.L. M type 1 and 3 group A streptococci stimulate tissue factor-mediated procoagulant activity in human monocytes and endothelial cells. Infect Immun 2003, 71:1903-1910.
111. Påhlman L.I., Malmström E., Mörgelin M., Herwald H. M protein from Streptococcus pyogenes induces tissue factor expression and pro-coagulant activity in human monocytes. Microbiology 2007, 153:2458-245864.
112. Påhlman L.I., Mörgelin M., Eckert J., et al. Streptococcal M protein: a multipotent and powerful inducer of inflammation. J Immunol 2006, 177:1221-1228.
113. Raeder R., Woischnik M., Podbielski A., Boyle M.D. A secreted streptococcal cysteine protease can cleave a surface-expressed M1 protein and alter the immunoglobulin binding properties. Res Microbiol 1998, 149:539-548.
114. Berge A., Björck L. Streptococcal cysteine proteinase releases biologically active fragments of streptococcal surface proteins. J Biol Chem 1995, 270:9862-9867.
115. Herwald H., Cramer H., Mörgelin M., et al. M protein, a classical bacterial virulence determinant, forms complexes with fibrinogen that induce vascular leakage. Cell 2004, 116:367-379.
116. Kurpiewski G.E., Forrester L.J., Campbell B.J., Barrett J.T. Platelet aggregation by Streptococcus pyogenes. Infect Immun 1983, 39:704-708.
117. Sjöbring U., Ringdahl U., Ruggeri Z.M. Induction of platelet thrombi by bacteria and antibodies. Blood 2002, 100:4470-4477.
118. Shannon O., Hertzén E., Norrby-Teglund A., Mörgelin M., Sjöbring U., Björck L. Severe streptococcal infection is associated with M protein-induced platelet activation and thrombus formation. Mol Microbiol 2007, 65:1147-1157.
119. Sun H., Ringdahl U., Homeister J.W., et al. Plasminogen is a critical host pathogenicity factor for group A streptococcal infection. Science 2004, 305:1283-1286.
120. Sriskandan S., Faulkner L., Hopkins P. Streptococcus pyogenes: Insight into the function of the streptococcal superantigens. Int J Biochem Cell Biol 2007, 39:12-19.
121. Nilsson M., Sørensen O.E., Mörgelin M., Weineisen M., Sjöbring U., Herwald H. Activation of human polymorphonuclear neutrophils by streptolysin O from Streptococcus pyogenes leads to the release of proinflammatory mediators. Thromb Haemost 2006, 95:982-990.
122. Tomai M., Kotb M., Majumdar G., Beachey E.H. Superantigenicity of streptococcal M protein. J Exp Med 1990, 172:359-362.
123. Fleischer B., Schmidt K.H., Gerlach D., Köhler W. Separation of T-cell-stimulating activity from streptococcal M protein. Infect Immun 1992, 60:1767-1770.
124. Degnan B., Taylor J., Hawkes C., et al. Streptococcus pyogenes type 5M protein is an antigen, not a superantigen, for human T cells. Hum Immunol 1997, 53:206-215.
125. Påhlman L.I., Olin A.I., Darenberg J., et al. Soluble M1 protein of Streptococcus pyogenes triggers potent T cell activation. Cell Microbiol 2008, 10:404-414.
126. Collin M., Olsén A. Generation of a mature streptococcal cysteine proteinase is dependent on cell wall-anchored M1 protein. Mol Microbiol 2000, 36:1306-1318.
127. Holub M., Helcl M., Beran O., Hnyková J., Příhodová J. Kinetics of immune parameters in a patient with sepsis caused by Streptococcus pyogenes treated with activated protein C. Scand J Infect Dis 2004, 36:485-488.
128. Sigurdardottir T, Björck V, Herwald H, et al. M1 protein from Streptococcus pyogenes induces nitric oxidemediated vascular hyporesponsiveness to phenylephrine: involvement of toll-like receptor activation. Shock 2009; in press.
129. Eliasson M., Frick I.M., Collin M., Sørensen O.E., Björck L., Egesten A. M1 protein of Streptococcus pyogenes increases production of the antibacterial CXC chemokine MIG/CXCL9 in pharyngeal epithelial cells. Microb Pathog 2007, 43:224-233.
130. Gautam N., Olofsson A.M., Herwald H., et al. Heparin-binding protein (HBP/CAP37): a missing link in neutrophil-evoked alteration of vascular permeability. Nat Med 2001, 7:1123-1127.
131. Soehnlein O., Oehmcke S., Ma X., et al. Neutrophil degranulation mediates severe lung damage triggered by streptococcal M1 protein. Eur Respir J 2008, 32:405-412.
132. Oehmcke S., Mörgelin M., Herwald H. Activation of the human contact system on neutrophil extracellular traps. J Innate Immun 2009, 1:225-231.
133. Brinkmann V., Reichard U., Goosmann C., et al. Neutrophil extracellular traps kill bacteria. Science 2004, 303:1532-1535.
134. Medina E. Neutrophil extracellular traps: a strategic tactic to defeat pathogens with potential consequences for the host. J Innate Immun 2009, 1:176-180.
135. Lauth X., von Köckritz-Blickwede M., McNamara C.W., et al. M1 Protein allows Group A Streptococcal survival in phagocyte extracellular traps through cathelicidin inhibition. J Innate Immun 2009, 1:202-214.
136. Buchanan J.T., Simpson A.J., Aziz R.K., et al. DNase expression allows the pathogen group A Streptococcus to escape killing in neutrophil extracellular traps. Curr Biol 2006, 16:396-400.